Transgenic Mouse Models for Prostate Cancer: Identification of an Androgen-Dependent Promoter and Creation and Characterization
An appropriate model to study the complex process of prostate tumorigenesis needs to reflect at least some aspects of the human disease presented in the clinic. The progression of prostate cancer includes the development of high-grade prostatic intraepithelial neoplasia (HGPIN, the precursor lesion for usual peripheral zone prostate cancer) (1 ), invasion, growth and potential dedifferentiation of organ confined tumor (2 ), extension outside of the prostate (either before or after local therapy), development of metastasis, and the progression from androgen-dependent (AD) to androgen-independent (AI) disease (3 ). Clinical observations have shown that androgen withdrawal has the greatest impact on the development and progression of prostate cancer. Therefore, androgen deprivation has been the gold standard in treating patients who have advanced prostate cancer (4 ,5 ). More than 80% of such patients show a favorable response, as evidenced by a decrease in serum prostate-specific antigen (PSA) levels and tumor regression, but tumor growth could resume despite continuous treatment (6 ). Although the progressive development of AI is poorly understood, the androgen receptor (AR) appears to be pivotal in the progression from AD to AI prostate cancer. Four possible mechanisms by which the AR may be actively involved in the development of AI include (1) mutations in the AR (5 ,7 –11 ); (2) AR amplification (12 ,13 ); (3) ligand-independent activation of AR through other signaling pathways (14 –22 ); and (4) altered activity of AR coregulators (either co-activators or co-inhibitors) (22 –24 ).
- Determination of Cyclin D1 Expression by Quantitative Real-Time, Reverse-Transcriptase Polymerase Chain Reaction
- Cloning of Immunoglobulin Chromosomal Translocations by Long-Distance Inverse Polymerase Chain Reaction
- Cyclooxygenase Inhibitors Induce Colon Cancer Cell Apoptosis Via PPAR 14-3-3 Pathway
- Gene Expression Profiling of Leukemia Stem Cells
- Epigenome and DNA Methylation in Oral Squamous Cell Carcinoma
- Neoadjuvant Endocrine Therapy Models
- Characterization of Signalling Pathways by Reverse Phase Protein Arrays
- Production of Antibody Fragments in a Bioreactor
- 腺病毒能在293中復(fù)制嗎?
- Mutational Analysis of the Neurofibromatosis Type 1 Gene in Childhood Myelodysplastic Syndromes Using a Protein Truncation Assay